EntreMed's arthritis drug shows promise
10th Oct 2005, 14:54 GMT
EntreMed reported that preclinical trials of its experimental treatment for rheumatoid arthritis showed positive results.
EntreMed's arthritis drug shows promise related news:
- FDA approves extended arthritis indications for Abbott's Humira — Pharmaceutical Business Review Online
- Synthetic protein could yield arthritis cure — Health News
- Potential Arthritis Drug Falls Short — MedicineNet Arthritis Specialty
- Novartis drug shows promise against malaria. — Environmental Health News
- FDA OKs 2 New Uses for Arthritis Drug Humira — WebMD Health Headlines
- Malaria Drug Shows Promise — WSJ.com: What's News Europe
- Chronic arthritis pain and the disappointment of u-opioid therapy — Medical News Today RSS/XML Feed
- Synthetic protein eases arthritis symptoms in mice — EurekAlert! - Medicine and Health
- Potential Arthritis Drug Falls Short (HealthDay) — Yahoo! Health: Back Pain News
- Synthetic human protein eases acute and chronic arthritis symptoms in mice — Medical News Today RSS/XML Feed
Latest news from bizjournals.com Health Care:Pharmaceuticals headlines:
- Synbiotics flu test gets OK from USDA
- Mesa Lab's numbers up
- Reliance Steel to offer $600M in notes
- Biotech firm expanding, completes office relocation
- Spectrum Pharmaceuticals settles with GlaxoSmithKline
- Study: Bioenergy sugar product useful for chronic fatigue syndrome
- IBT Labs will spend $2M to expand division
- InnoCentive to help push $1M prize for discoveries in ALS
- Mercury, BU team says biotech app cuts processing time to minutes
- Omnicare to pay $49.5M in civil settlement